Top Markets
#1 ADO Protocol ADO Protocol +193.34%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +44.27%
#4 GAIB AID GAIB AID +24.67%
#5 SkyAI SkyAI +14.39%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.48%
#8 Tutorial Tutorial +12.27%
#9 Casper Network Casper Network +12.23%
#10 Pons Pons +12.22%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rang in aandelen #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aandeelprijs
$0.5099
Laatst gesynchroniseerd: 2024-10-15
Marktkapitalisatie
$7.60M
Verandering (1 dag)
2.02%
Verandering (1 jaar)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Categorie

Healthcare
Winst voor Anew Medical, Inc. (WENA)
Winst in Jun 2024 TTM: $114.12K
Volgens de meest recente financiële verslagen van Anew Medical, Inc. bedraagt de huidige winst van het bedrijf $114.12K. In 2022 behaalde het bedrijf een winst van $1.56M, een stijging ten opzichte van de winst van 2021, die $-1.11M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Anew Medical, Inc. van 2021 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE